These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9692272)

  • 1. A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
    Landabaso MA; Iraurgi I; Jiménez-Lerma JM; Sanz J; Fernádez de Corres B; Araluce K; Calle R; Gutiérrez-Fraile M
    Addiction; 1998 May; 93(5):739-44. PubMed ID: 9692272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].
    Krupitskiĭ EM; Zvartau EE; Tsoĭ-Podosenin MV; Masalov DV; Burakov AM; Egorova VIu; Didenko TIu; Romanova TN; Ivanova EB; Bespalov AIu; Verbitskaia EV; Neznanov NG; Grineneko AIa; O'Brien C; Woody D
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 2):44-54. PubMed ID: 21322147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
    Neumeister A; Winkler A; Wöber-Bingöl C
    Am J Psychiatry; 1999 May; 156(5):797. PubMed ID: 10327921
    [No Abstract]   [Full Text] [Related]  

  • 5. Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment.
    Gerra G; Fertonani G; Zaimovic A; Rota-Graziosi I; Avanzini P; Caccavari R; Delsignore R; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1225-37. PubMed ID: 8868205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention].
    Grinenko AIa; Krupitskiĭ EM; Zvartau EE
    Vestn Ross Akad Med Nauk; 2003; (10):54-6. PubMed ID: 14598513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone for the treatment of trichotillomania: a case report.
    Carrion VG
    J Clin Psychopharmacol; 1995 Dec; 15(6):444-5. PubMed ID: 8748437
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence.
    Farren CK; O'Malley S
    Am J Addict; 2002; 11(3):228-34. PubMed ID: 12202015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
    Tiihonen J; Krupitsky E; Verbitskaya E; Blokhina E; Mamontova O; Föhr J; Tuomola P; Kuoppasalmi K; Kiviniemi V; Zwartau E
    Am J Psychiatry; 2012 May; 169(5):531-6. PubMed ID: 22764364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
    Farren CK; O'Malley SS
    Am J Psychiatry; 1999 Aug; 156(8):1258-62. PubMed ID: 10450269
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence.
    Kirchmayer U; Davoli M; Verster AD; Amato L; Ferri A; Perucci CA
    Addiction; 2002 Oct; 97(10):1241-9. PubMed ID: 12359026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three methods of opioid detoxification in a primary care setting. A randomized trial.
    O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
    Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats.
    Rezvani AH; Overstreet DH; Mason GA; Janowsky DS; Hamedi M; Clark E; Yang Y
    Alcohol Alcohol; 2000 Jan; 35(1):76-83. PubMed ID: 10684782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
    Nunes EV; Bisaga A; Krupitsky E; Nangia N; Silverman BL; Akerman SC; Sullivan MA
    Addiction; 2020 Feb; 115(2):239-246. PubMed ID: 31313402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
    Yang G; Zhou W; Xu K
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
    Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
    Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A
    Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventing weight gain in smoking cessation: there is no miracle solution].
    Nanchen D; Willi C; Peytremann-Bridevaux I; Burnand B; Walther MR
    Rev Med Suisse; 2009 Aug; 5(212):1577. PubMed ID: 19728455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.